Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Jullien

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Transplantation|March 14, 2014
Skin cancers after liver transplantation: retrospective single-center study on 371 recipientsEmilie Ducroux, Olivier Boillot, Maria Andrea Ocampo, et al.
JAMA Dermatology|December 6, 2023
Treatment of Severe Palmoplantar Pustular Psoriasis With BimekizumabThierry Passeron, Jean-Luc Perrot, Denis Jullien, et al.
Molecular and Cellular Biology|January 26, 2002
The AT-hook protein D1 is essential for Drosophila melanogaster development and is implicated in position-effect variegationNathalie Aulner, Caroline Monod, Guillaume Mandicourt, et al.
European Journal of Dermatology : EJD|June 25, 2008
Comparative study of stress and quality of life in outpatients consulting for different dermatoses in 5 academic departments of dermatologyLaurent Misery, Luc Thomas, Denis Jullien, et al.
Dermatology and Therapy|May 3, 2025
Efficacy and Safety of Apremilast Over 52 Weeks in Patients with Plaque Psoriasis in High-Impact Areas and Impaired Quality of LifeMatthias Augustin, Jonathan Barker, Curdin Conrad, et al.
Dermatology and Therapy|March 8, 2026
Real-World Burden of Generalized Pustular Psoriasis in a French Observational Study: Prevalence, Incidence, Healthcare Resource Utilization, Comorbidities, Treatment Use, and MortalityManuelle Viguier, Denis Jullien, Laurent Misery, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 27, 2022
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trialUlrich Mrowietz, Jonathan Barker, Curdin Conrad, et al.
European Journal of Dermatology : EJD|July 29, 2005
Pathological score for the evaluation of allograft rejection in human hand (composite tissue) allotransplantationJean Kanitakis, Palmina Petruzzo, Denis Jullien, et al.
Joint Bone Spine|September 18, 2025
Skin cancer risk in patients with non-dermatologic immune-mediated inflammatory diseasesJean-Guillaume Letarouilly, Pauline Wils, Delphine Staumont-Sallé, et al.
Journal of Cell Science|May 22, 2016
Chromatibody, a novel non-invasive molecular tool to explore and manipulate chromatin in living cellsDenis Jullien, Julien Vignard, Yoann Fedor, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Transplantation|March 14, 2014
Skin cancers after liver transplantation: retrospective single-center study on 371 recipientsEmilie Ducroux, Olivier Boillot, Maria Andrea Ocampo, et al.
JAMA Dermatology|December 6, 2023
Treatment of Severe Palmoplantar Pustular Psoriasis With BimekizumabThierry Passeron, Jean-Luc Perrot, Denis Jullien, et al.
Molecular and Cellular Biology|January 26, 2002
The AT-hook protein D1 is essential for Drosophila melanogaster development and is implicated in position-effect variegationNathalie Aulner, Caroline Monod, Guillaume Mandicourt, et al.
European Journal of Dermatology : EJD|June 25, 2008
Comparative study of stress and quality of life in outpatients consulting for different dermatoses in 5 academic departments of dermatologyLaurent Misery, Luc Thomas, Denis Jullien, et al.
Dermatology and Therapy|May 3, 2025
Efficacy and Safety of Apremilast Over 52 Weeks in Patients with Plaque Psoriasis in High-Impact Areas and Impaired Quality of LifeMatthias Augustin, Jonathan Barker, Curdin Conrad, et al.
Dermatology and Therapy|March 8, 2026
Real-World Burden of Generalized Pustular Psoriasis in a French Observational Study: Prevalence, Incidence, Healthcare Resource Utilization, Comorbidities, Treatment Use, and MortalityManuelle Viguier, Denis Jullien, Laurent Misery, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 27, 2022
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trialUlrich Mrowietz, Jonathan Barker, Curdin Conrad, et al.
European Journal of Dermatology : EJD|July 29, 2005
Pathological score for the evaluation of allograft rejection in human hand (composite tissue) allotransplantationJean Kanitakis, Palmina Petruzzo, Denis Jullien, et al.
Joint Bone Spine|September 18, 2025
Skin cancer risk in patients with non-dermatologic immune-mediated inflammatory diseasesJean-Guillaume Letarouilly, Pauline Wils, Delphine Staumont-Sallé, et al.
Journal of Cell Science|May 22, 2016
Chromatibody, a novel non-invasive molecular tool to explore and manipulate chromatin in living cellsDenis Jullien, Julien Vignard, Yoann Fedor, et al.
Pageof 11